The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Attention Score in Context
Title |
Efficacy and safety of hybutimibe in combination with atorvastatin for treatment of hypercholesteremia among patients with atherosclerotic cardiovascular disease risk equivalent: A multicenter, randomized, double-blinded phase III study
|
---|---|
Published in |
Frontiers in Cardiovascular Medicine, August 2022
|
DOI | 10.3389/fcvm.2022.888604 |
Pubmed ID | |
Authors |
Litong Qi, Jiyan Chen, Xiaodong Li, Xiaoyong Qi, Chunhua Ding, Xiaoping Chen, Xiang Gu, Wenliang Xiao, Shuiping Zhao, Yugang Dong, Mingqi Zheng, Kai Huang, Liangqiu Tang, Xiaomei Guo, Fang Wang, Guosheng Fu, Junxia Li, Yong Huo |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Canada | 1 | 33% |
Switzerland | 1 | 33% |
Unknown | 1 | 33% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 100% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 September 2022.
All research outputs
#16,665,631
of 24,520,187 outputs
Outputs from Frontiers in Cardiovascular Medicine
#3,171
of 8,473 outputs
Outputs of similar age
#226,784
of 392,465 outputs
Outputs of similar age from Frontiers in Cardiovascular Medicine
#357
of 1,020 outputs
Altmetric has tracked 24,520,187 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,473 research outputs from this source. They receive a mean Attention Score of 4.2. This one has gotten more attention than average, scoring higher than 59% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 392,465 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 30th percentile – i.e., 30% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,020 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.